MICRO-X LIMITED — Investor Presentation 2017

Mar 21, 2017

Ltd

ACN 153 273 735

Investor Update by Peter Rowland Managing Director, Micro-X Ltd. 23[rd] March, 2017

==> picture [161 x 46] intentionally omitted <==

Commercial-in-Confidence

© Micro-X Ltd 2017

Company Quality Accreditation :

ISO 13485 Accreditation Recommended 3[rd] March 2017.

• BSI Stage Two Audit successful - Certificate expected shortly

• Company-wide Quality Management System is recognised to meet Medical Device Directorate standards for all company processes operating in

• Design

• Manufacturing

• Quality

• Supply chain management

• Necessary for CE Marking

==> picture [161 x 46] intentionally omitted <==

Commercial-in-Confidence

© Micro-X Ltd 2017

Regulatory Approvals:

‘K’ Number received from FDA: 15[th] March 2017.

• FDA acknowledge receipt of a complete & valid 510(k) submission

• Product marketing can now commence

• • Approval time normally 90 days

• Health Canada Licence Application submitted to Therapeutic Products Directorate

• Declaration of Conformity (for CE Marking) data preparation well advanced

==> picture [161 x 46] intentionally omitted <==

Commercial-in-Confidence

© Micro-X Ltd 2017

Reliability Growth Testing:

Achieved RG Target 8[th] March 2017.

• Normal Operation:

• 60 x-ray shots/day = 22,000 per annum

• Target for Mean Time Between Failures is 11,000 cycles

• RGT Program

• 3 carts, 50 circuits/shift, 3 shifts/day

• Reliability Target set at 130,000 cycles

• Currently at 180,000 cycles (8 years life)

==> picture [339 x 281] intentionally omitted <==

• Continuing to add 1500 cycles per day

==> picture [161 x 46] intentionally omitted <==

Commercial-in-Confidence

© Micro-X Ltd 2017

Generating Strong Market Interest

• Enthusiastic customer interest shown at recent Trade Shows

• Carestream regional sales offices requesting additional units for demo/sale

• Pre-launch stocking order now planned for 2.5x earlier guidance with increasing momentum

==> picture [175 x 225] intentionally omitted <==

European Congress of Radiology, Vienna, 2[nd] March 2017

==> picture [192 x 213] intentionally omitted <==

Arab Health, Dubai, 30[th] January 2017

==> picture [161 x 46] intentionally omitted <==

Commercial-in-Confidence

© Micro-X Ltd 2017

Pathway to Launch :

• Service Training under way at Carestream HQ

• Hospital Trade Trials in Canada on receipt of TPD Licence

• Nano featured in more major Trade Shows:

• Genoa, Italy, 6[th] April

• Sao Paulo, Brazil, 4[th] May

• Leipzig, Germany, 24[th] May

• Manchester, UK, 12[th] June

• Nano production rate increases for Carestream:

  • Reliability demonstration

  • International Service & End-User Training

  • QA Evaluation

  • Internal Trials

  • Market Development

• Regulatory Approvals

==> picture [161 x 46] intentionally omitted <==

Commercial-in-Confidence

© Micro-X Ltd 2017

Thank You; Any questions?

© Micro-X Ltd 2017